跳至主要内容
临床试验/NCT04197180
NCT04197180招募中不适用

HybridAPC for the Treatment of Gastric Low Grade Intraepithelial Neoplasia (LGIN): a Prospective, Multi-center Study

Chinese University of Hong Kong2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
2
主要终点
Complete ablation of gastric low grade intraepithelial neoplasia

研究概览

简要总结

This cohort study aims to investigate the clinical efficacy and safety of Hybrid APC for treatment of gastric low grade intramucosal neoplasia.

详细描述

This cohort study aims to investigate the clinical efficacy and safety of Hybrid APC for treatment of gastric low grade intramucosal neoplasia. Successful ablation is defined as no evidence of local recurrence at 12 months after HybridAPC upon follow up endoscopy. This is defined as absence of LGIN, HGIN and cancer in biopsies obtained at all locations during followup endoscopy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Low grade intraepithelial neoplasia of stomach with size≤20 mm
  • Endoscopic diagnosis suspected gastric LGIN with biopsy confirmed gastric LGIN
  • Endoscopic appearance according to Paris classification of Type 0-IIa, IIb or IIc
  • Patients with informed consent

排除标准

  • Patients who had previous endoscopic treatment (including APC, EMR, ESD) for gastric LGIN, HGIN or gastric carcinoma.
  • Endoscopic evidence of ulcer
  • Biopsy confirmed HGIN
  • Endoscopic diagnosis suspected HGIN while biopsy confirmed LGIN
  • informed consent not available

结局指标

主要结局

Complete ablation of gastric low grade intraepithelial neoplasia

时间窗: 12 months

Successful ablation is defined as no evidence of local recurrence at 12 months after HybridAPC upon follow up endoscopy. This is defined as absence of LGIN, HGIN and cancer in biopsies obtained at all locations during followup endoscopy.

次要结局

  • Operative time(1 day)
  • Intraoperative bleeding(1 day)
  • Development of new neoplasia(12, 24 and 36 months)
  • Number of HybridAPC procedures required for treatment(12 months)
  • Pain after procedure(3 days)
  • Progression of Low grade intraepithelial neoplasia(12, 24 and 36 months)
  • Postoperative complications(7 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Philip Wai Yan CHIU

Professor

Chinese University of Hong Kong

研究点 (2)

Loading locations...

相似试验